All Stories

  1. Clinical phenotyping of chronic insomnia in early childhood: family-history–informed vulnerability profiles in a retrospective chart review
  2. Comparative Peripheral Blood Transcriptomic Profiles in Parkinson’s Disease and Restless Legs Syndrome: An Exploratory Between-Cohort Analysis
  3. Large Muscle Movements During Sleep Across the Synucleinopathy Spectrum: A Polysomnographic Study of Isolated REM Sleep Behavior Disorder and Parkinson’s Disease
  4. Protocol for the DREAMER study: Design and methodological framework of a multicenter trial-ready cohort of individuals with isolated REM sleep without atonia
  5. Repositioning Orexin in Sleep Medicine: From Wake Promotion to Sleep-State Control. A Treatment-Oriented Narrative Review
  6. REM sleep behavior disorder as a shared motor phenotype: A multidimensional clinical study
  7. Artificial intelligence for sleep instability and motor phenotyping: clinical translation beyond sleep staging
  8. Protocol for the DREAMER study: design and methodological framework of a multicenter trial-ready cohort of individuals with isolated REM sleep without atonia
  9. Adherence to the Mediterranean diet, inflammatory biomarkers and cognitive status in older Italian adults
  10. Update on Repetitive Transcranial Magnetic Stimulation in Post-Stroke Cognitive Rehabilitation: A Systematic Review of Randomized Clinical Trials
  11. Dream-enactment behaviors without REM sleep without atonia
  12. Immersive Technologies for Cognitive Rehabilitation in Dementia and Mild Cognitive Impairment: Systematic Review
  13. Neuropsychiatric and behavioural correlates of sundowning in Alzheimer’s disease
  14. Repetitive Transcranial Magnetic Stimulation for Spasticity in Stroke and Other Neuromotor Disorders: A Systematic Review of Randomized Clinical Trials
  15. Impaired interhemispheric inhibition in isolated REM sleep Behavior Disorder: first exploratory Transcranial Magnetic Stimulation-based evidence
  16. Transcranial Magnetic Stimulation in Parkinson’s Disease and Parkinsonian Syndromes: A Narrative Expert Review
  17. Dysregulation of miRNAs in Sicilian Patients with Autism Spectrum Disorder
  18. Anxiety-Related Functional Dizziness: A Systematic Review of the Recent Evidence on Vestibular, Cognitive Behavioral, and Integrative Therapies
  19. Transcranial Magnetic Stimulation in Parkinson’s Disease and Parkinsonian Syndromes: A “State-of-Art” Perspective
  20. Transcranial doppler detected right-to-left shunt is common but not associated with MRI white matter hyperintensity burden: a cross-sectional study
  21. Epigenetic Signatures in an Italian Cohort of Parkinson’s Disease Patients from Sicily
  22. Sex differences in clinical and prognostic trajectories in patients with idiopathic REM sleep behavior disorder: Insights from the FARPRESTO cohort
  23. Beyond the Sleep Lab: A Narrative Review of Wearable Sleep Monitoring
  24. Periodic limb movements during sleep and progression of sleep apnea: a longitudinal analysis from the Wisconsin sleep cohort
  25. Antidepressant and Related Neurobiological and Neurophysiological Effects of Add-On Transcranial Direct Current Stimulation in Major Depressive Disorder with Residual Symptoms: A Randomized, Double-Blind Clinical Trial Protocol
  26. Dysregulation of miRNAs in Sicilian Patients with Huntington’s Disease
  27. Exploring the Role of Ferroptosis in the Pathophysiology and Circadian Regulation of Restless Legs Syndrome
  28. Odontophobia Across the Lifespan: Clinical Perspectives, Vulnerable Populations, and Inclusive Strategies for Dental Anxiety Management
  29. Protein Expression of TXNIP in the Dopaminergic Neurons of Subjects with Parkinson’s Disease: Evidence from a Pilot Study
  30. Autonomic correlates of large muscle group movements during non-REM sleep in restless legs syndrome: a comparative analysis with periodic and non-periodic leg movements
  31. Management and Treatment of Carotid Stenosis: Overview of Therapeutic Possibilities and Comparison Between Interventional Radiology, Surgery and Hybrid Procedure
  32. Alteration of Metabolic Profile in Patients with Narcolepsy Type 1
  33. Moving beyond muscle atonia: rapid eye movement sleep microstructure as a biomarker in sleep behavior disorder
  34. Sex differences in cerebrospinal fluid proteomics of patients with restless legs syndrome
  35. Neuroprotective effects of rTMS in chronic insomnia: is glymphatic system modulation the key player?
  36. Transcriptome Study in Sicilian Patients with Huntington’s Disease
  37. Strengthening the link between periodic leg movements during sleep and cerebral small vessel disease
  38. Chronotype and Cancer: Emerging Relation Between Chrononutrition and Oncology from Human Studies
  39. Evidence of Involvement of the Calcitonin Gene‐Related Peptide in Restless Legs Syndrome
  40. Transcranial Doppler sonography follow-up study in mild vascular cognitive impairment
  41. Evaluating the differential effects of dopamine agonists and clonazepam on large muscle group movements in restless legs syndrome
  42. Event-related potentials as neurophysiological predictors of high-risk isolated REM sleep behavior disorder patients
  43. Unraveling the pathophysiology of restless legs syndrome from multimodal MRI techniques: A systematic review
  44. Sleep and sleep disorders
  45. Age‐related changes in large muscle group movements during sleep
  46. The Role of ETNPPL in Dopaminergic Neuron Stability: Insights from Neuromelanin-Associated Protein Expression in Parkinson’s Disease
  47. Intersection of Sleep Disorders and Parkinson Disease: Unveiling the Bidirectional Relationship
  48. Exploring sex differences in periodic leg movements during sleep across the lifespan of patients with restless legs syndrome
  49. Response to iron supplementation is similar between boys and girls with pediatric sleep movement disorders
  50. The Fascinating Link between Psychedelics and Neuroplasticity
  51. Combined Effect of Red Wine and Mocha Pot Coffee in Mild Vascular Cognitive Impairment
  52. Sex‐based disparities in dopamine agonist response in patients with restless legs syndrome
  53. Sensory aspects of restless legs syndrome: Clinical, neurophysiological and neuroimaging prospectives
  54. The Triad of Sleep, Immunity, and Cancer: A Mediating Perspective
  55. Transcriptome Study in Sicilian Patients with Autism Spectrum Disorder
  56. The dynamics of cyclic‐periodic phenomena during non‐rapid and rapid eye movement sleep
  57. Large muscle group movements during sleep in restless leg syndrome: neurophysiological and clinical implications
  58. Targeting the adenosinergic system in restless legs syndrome: A pilot, “proof-of-concept” placebo-controlled TMS-based protocol
  59. A survey-based approach on restless legs syndrome: practices and perspectives among Italian neurologists
  60. Unveiling the pathophysiology of restless legs syndrome through transcriptome analysis
  61. A narrative review on insomnia and hypersomnolence within Major Depressive Disorder and bipolar disorder: A proposal for a novel psychometric protocol
  62. Changes in time structure of periodic leg movements during sleep in restless legs syndrome: Effects of sex and age
  63. Current opinions and practices in post-stroke movement disorders: Survey of movement disorders society members
  64. Relation between dietary inflammatory potential and sleep features: Systematic review of observational studies
  65. Setting research priorities for global pandemic preparedness: An international consensus and comparison with ChatGPT’s output
  66. A Topical Review on Transcranial Magnetic Stimulation in Restless Legs Syndrome
  67. Polysomnographic features associated with clonazepam and melatonin treatment in isolated REM sleep behavior disorder: Time for new therapeutic approaches?
  68. Efficacy and safety of ketamine and esketamine for unipolar and bipolar depression: an overview of systematic reviews with meta-analysis
  69. Mediterranean Diet and Sleep Features: A Systematic Review of Current Evidence
  70. Pain-Free Alpha-Synuclein Detection by Low-Cost Hierarchical Nanowire Based Electrode
  71. Gene Expression Profiling of Post Mortem Midbrain of Parkinson’s Disease Patients and Healthy Controls
  72. REHASTART: Cognitive Tele-Rehabilitation Empowered by Vision Transformers
  73. Transcriptome Analysis in Patients With Muscle-invasive Bladder Cancer
  74. COVID‐19 and Mental Health: A “Pandemic Within a Pandemic”
  75. Interdisciplinary Multidimensional Assessment of Transthyretin Amyloidosis before and after Tafamidis
  76. Editorial: Application of noninvasive neuromodulation in cognitive rehabilitation
  77. A Next-Generation Sequencing Study in a Cohort of Sicilian Patients with Parkinson’s Disease
  78. Transcranial Magnetic Stimulation for the Treatment of Gambling Disorder: A Systematic Review
  79. Psychophysiology of Sleep
  80. Gene Expression Profiling of Post Mortem midbrain of Parkinson’s Disease patients and Healthy Controls
  81. Neuroanatomical findings in isolated REM sleep behavior disorder and early Parkinson’s disease: a Voxel-based morphometry study
  82. “Mind” versus “Body” in Mild Cognitive Impairment Rehabilitation: Does a Multicomponent Physical Exercise Program Have a Dichotomous Effect on Cognitive Functions and Physical Performance?
  83. Mediterranean diet and chronotype: Data from Italian adults and systematic review of observational studies
  84. Special Issue “Sleep Disorders: From Clinical Research to Daily Practice”
  85. Sex-specific reference values for total, central, and peripheral latency of motor evoked potentials from a large cohort
  86. Editorial: Nutrients and brain: from bench to the bedside
  87. Considering REM Sleep Behavior Disorder in the Management of Parkinson’s Disease
  88. ESOC 2023 Abstract Book
  89. Mediterranean diet, mental health, cognitive status, quality of life, and successful aging in southern Italian older adults
  90. The Y831C Mutation of the POLG Gene in Dementia
  91. Severity of REM sleep without atonia correlates with measures of cognitive impairment and depressive symptoms in REM sleep behaviour disorder
  92. Reply: Post‐COVID‐19 Myoclonus‐Ataxia Syndrome—Is there Really a Need for Intravenous Immunoglobulin Treatment in all Cases?
  93. Challenging the Pleiotropic Effects of Repetitive Transcranial Magnetic Stimulation in Geriatric Depression: A Multimodal Case Series Study
  94. Dietary Fats and Cognitive Status in Italian Middle-Old Adults
  95. Sleep counts! Role and impact of sleep in the multimodal management of multiple sclerosis
  96. Progression of clinical markers in prodromal Parkinson’s disease and dementia with Lewy bodies: a multicentre study
  97. Sex differences in mild vascular cognitive impairment: A multimodal transcranial magnetic stimulation study
  98. Central and Peripheral Nervous System Complications of Vasculitis Syndromes from Pathology to Bedside: Part 2—Peripheral Nervous System
  99. Neurobiology and Applications of Inositol in Psychiatry: A Narrative Review
  100. Repetitive transcranial magnetic stimulation in primary sleep disorders
  101. Dietary Fats and Depressive Symptoms in Italian Adults
  102. Transcranial magnetic stimulation for the treatment of gambling disorder (GD): a systematic review
  103. Targeting Orexin Receptors for the Treatment of Insomnia: From Physiological Mechanisms to Current Clinical Evidence and Recommendations
  104. The supporting (sometimes decisive!) role of transcranial magnetic stimulation in forensic medicine
  105. Role and Dysregulation of miRNA in Patients with Parkinson’s Disease
  106. Endothelial Reprogramming in Sports Traumatology: Role of the Widespread Neuro-Immuno-Endocrine-Endothelial System
  107. Celiac Disease and Neurological Manifestations: From Gluten to Neuroinflammation
  108. Abstracts of the 52nd Annual Conference of the Italian Society of Neurology
  109. Diabetic Striatopathy: Parenchymal Transcranial Sonography as a Supplement to Diagnosis at the Emergency Department
  110. Acute Cerebellar Ataxia and Myoclonus in SARS‐CoV ‐2–Related Encephalopathy Responsive to Immunotherapy: A Case Series
  111. PC012 / #460 MULTIMODAL EFFECTS OF REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION ON PATIENTS WITH MAJOR DEPRESSION AND VASCULAR DEPRESSION: A PILOT STUDY
  112. A comprehensive review of transcranial magnetic stimulation in secondary dementia
  113. Cerebral hemodynamic changes to transcranial Doppler sonography in celiac disease: A pilot study
  114. Post–COVID‐19 Myoclonus–Ataxia Syndrome Responsive to Intravenous Immunoglobulins
  115. TU-225. Electrocortical overlap between isolated RBD and Parkinson’s disease with RBD: A pilot TMS study
  116. A Systematic Review on the Effect of Nutraceuticals on Antidepressant-Induced Sexual Dysfunctions: From Basic Principles to Clinical Applications
  117. Repetitive transcranial magnetic stimulation for post-traumatic stress disorder: Lights and shadows
  118. Examples of Inverse Comorbidity between Cancer and Neurodegenerative Diseases: A Possible Role for Noncoding RNA
  119. Fabry’s Disease: The Utility of a Multidisciplinary Screening Approach
  120. Reduced Intracortical Facilitation to TMS in Both Isolated REM Sleep Behavior Disorder (RBD) and Early Parkinson’s Disease with RBD
  121. Research priorities to reduce the impact of COVID-19 in low- and middle-income countries
  122. Neurological Presentation of Giant Pituitary Tumour Apoplexy: Case Report and Literature Review of a Rare but Life-Threatening Condition
  123. Daily mocha coffee intake and psycho-cognitive status in non-demented non-smokers subjects with subcortical ischaemic vascular disease
  124. Phenolic Acids and Prevention of Cognitive Decline: Polyphenols with a Neuroprotective Role in Cognitive Disorders and Alzheimer’s Disease
  125. A Transcriptome Analysis of mRNAs and Long Non-Coding RNAs in Patients with Parkinson’s Disease
  126. Post-stroke aphasia at the time of COVID-19 pandemic: a telerehabilitation perspective
  127. Sleep and homeostatic control of plasticity
  128. Central and Peripheral Nervous System Complications of Vasculitis Syndromes From Pathology to Bedside: Part 1—Central Nervous System
  129. Preserved central cholinergic functioning to transcranial magnetic stimulation in de novo patients with celiac disease
  130. Morphological analysis of the brain subcortical gray structures in restless legs syndrome
  131. Objective and quantitative evaluation of fetal hiccups by computerized cardiotocography: a prospective observational study
  132. Neurophysiological Aspects of REM Sleep Behavior Disorder (RBD): A Narrative Review
  133. Increased Serum Prolactin and Excessive Daytime Sleepiness: An Attempt of Proof-of-Concept Study
  134. A Review on P300 in Obsessive-Compulsive Disorder
  135. Impact of COVID-19 pandemic on the neuropsychiatric status of Wilson’s disease
  136. Diagnostic contribution and therapeutic perspectives of transcranial magnetic stimulation in dementia
  137. Transcallosal motor disinhibition to transcranial magnetic stimulation in de novo patients with Celiac disease
  138. Transcranial doppler ultrasonography study in migraine patients treated with erenumab
  139. Late Breaking Abstracts
  140. Editorial: Non-invasive Brain Stimulation in the Study and Modulation of Metaplasticity in Neurological Disorders
  141. Cognitive Impairment in Inpatients with Prurigo Nodularis and Psychiatric Comorbidities
  142. Intracortical and Intercortical Motor Disinhibition to Transcranial Magnetic Stimulation in Newly Diagnosed Celiac Disease Patients
  143. An unusual gait disorder at the Emergency Department: role of the quantitative assessment of parenchymal transcranial Doppler sonography
  144. MMN in BD
  145. mRNA expression profiling of mitochondrial subunits in subjects with Parkinson’s disease
  146. Moderate Mocha Coffee Consumption Is Associated with Higher Cognitive and Mood Status in a Non-Demented Elderly Population with Subcortical Ischemic Vascular Disease
  147. Neurological Sequelae in Patients with COVID-19: A Histopathological Perspective
  148. Hypertensive Crisis in Acute Cerebrovascular Diseases Presenting at the Emergency Department: A Narrative Review
  149. Repetitive TMS for the “cognitive tsunami” of sleep deprivation
  150. Clinical and Electrophysiological Hints to TMS in De Novo Patients with Parkinson’s Disease and Progressive Supranuclear Palsy
  151. SARS-CoV-2 pathophysiology and its clinical implications: An integrative overview of the pharmacotherapeutic management of COVID-19
  152. Abstracts of the 51st Annual Conference of the Italian Society of Neurology
  153. TMS Correlates of Pyramidal Tract Signs and Clinical Motor Status in Patients with Cervical Spondylotic Myelopathy
  154. Evaluation and Treatment of Vascular Cognitive Impairment by Transcranial Magnetic Stimulation
  155. Hepatitis C Virus Infection Increases Fatigue in Health Care Workers
  156. Screening for Fabry Disease in Kidney Transplant Recipients: Experience of a Multidisciplinary Team
  157. A Customized Next-Generation Sequencing-Based Panel to Identify Novel Genetic Variants in Dementing Disorders: A Pilot Study
  158. Cerebral Hemodynamic Changes to Transcranial Doppler in Asymptomatic Patients with Fabry’s Disease
  159. SARS-CoV-2 and the Nervous System: From Clinical Features to Molecular Mechanisms
  160. Repetitive TMS for sleep disorders: are we ready?
  161. The present and the future of Transcranial Magnetic Stimulation in Restless Legs Syndrome
  162. Pharmacotherapeutic management of lower urinary tract symptoms in Multiple Sclerosis patients
  163. Acetyl-L-Carnitine in Dementia and Other Cognitive Disorders: A Critical Update
  164. ePoster Sessions
  165. Late-onset oro-facial dyskinesia in Spinocerebellar Ataxia type 2: a case report
  166. Update on the Neurobiology of Vascular Cognitive Impairment: From Lab to Clinic
  167. P21 TMS correlates of pyramidal signs and clinical motor status: Insights from a spinal perspective
  168. “Self-Neuroenhancement”: The Last Frontier of Noninvasive Brain Stimulation?
  169. The added value of parenchymal transcranial Doppler sonography at the Emergency Room: case report of an unusual gait disorder
  170. The added value of parenchymal transcranial Doppler sonography at the Emergency Room: case report of an unusual gait disorder
  171. “Mute” plantar response: does the cortico-spinal tract “speak”?
  172. Motor activity and Becker’s muscular dystrophy: lights and shadows
  173. Decrease in Serum Vitamin D Level of Older Patients with Fatigue
  174. Facilitatory/inhibitory intracortical imbalance in REM sleep behavior disorder: early electrophysiological marker of neurodegeneration?
  175. Migrainous Infarction And Cerebral Vasospasm: Case Report And Literature Review
  176. Invited Faculty Abstracts from the International Neuromodulation Society’s 14th World Congress
  177. A Customized NGS-Based Resequencing Gene Panel to Identify Genetic Variants in Dementing Disorders: Preliminary Results
  178. Update on intensive motor training in spinocerebellar ataxia: time to move a step forward?
  179. Adjunct Diagnostic Value of Transcranial Magnetic Stimulation in Mucopolysaccharidosis-Related Cervical Myelopathy: A Pilot Study
  180. Fear and disgust: case report of two uncommon emotional disturbances evoked by visual disperceptions after a right temporal-insular stroke
  181. Fear and disgust: case report of two uncommon emotional disturbances evoked by visual disperceptions after a right temporal-insular stroke
  182. Diagnostic and Prognostic Value of Transcranial Magnetic Stimulation in Mucopolysaccharidosis-Related Cervical Myelopathy
  183. Age, Height, and Sex on Motor Evoked Potentials: Translational Data From a Large Italian Cohort in a Clinical Environment
  184. Transcranial Doppler ultrasound in vascular cognitive impairment-no dementia
  185. Vitamin D Serum Levels in Patients with Statin-Induced Musculoskeletal Pain
  186. Clinical and neuroplastic effect of inhibitory rTMS on the sensory-motor cortical areas in RLS: a proof of concept study
  187. Fear and disgust: case report of two uncommon emotional disturbances evoked by visual disperceptions after a right temporal-insular stroke
  188. Interpreting Genetic Variants: Hints from a Family Cluster of Parkinson’s Disease
  189. Comment on “Shiatsu as an Adjuvant Therapy for Depression in Patients With Alzheimer’s Disease: A Pilot Study”
  190. Large expert-curated database for benchmarking document
  191. Repetitive transcranial magnetic stimulation in stroke rehabilitation: review of the current evidence and pitfalls
  192. The neurophysiology of hyperarousal in restless legs syndrome: Hints for a role of glutamate/GABA
  193. Cognitive Impairment and Celiac Disease: Is Transcranial Magnetic Stimulation a Trait d’Union between Gut and Brain?
  194. Impaired Cerebral Haemodynamics in Vascular Depression: Insights From Transcranial Doppler Ultrasonography
  195. Impaired short-term plasticity in restless legs syndrome: a pilot rTMS study
  196. Shiatsu as an adjuvant therapy for depression in patients with Alzheimer’s disease: A pilot study
  197. Early-onset subcortical ischemic vascular dementia in an adult with mtDNA mutation 3316G>A
  198. Clinical and electrophysiological impact of repetitive low-frequency transcranial magnetic stimulation on the sensory–motor network in patients with restless legs syndrome
  199. Motor and Perceptual Recovery in Adult Patients with Mild Intellectual Disability
  200. Neurophysiology of the “Celiac Brain”: Disentangling Gut-Brain Connections
  201. Nerve Conduction Studies as a Measure of Disease Progression: Objectivity or Illusion?
  202. Cortical Plasticity in Depression
  203. Towards the concept of disease-modifier in post-stroke or vascular cognitive impairment: a consensus report
  204. Cortical involvement in celiac disease before and after long-term gluten-free diet: A Transcranial Magnetic Stimulation study
  205. Central and peripheral nervous system excitability in restless legs syndrome
  206. Impaired rTMS-induced short-term neuroplasticity in restless legs syndrome: a pilot study
  207. P008 Long term neurophysiological effects of the gluten-free diet in adult celiac patients: A TMS study
  208. Prominent neurological involvement in Dercum disease
  209. Retroclival subdural hematoma after a lumbar puncture: An uncommon complication for a common procedure
  210. Unusual Neurological Presentation of Nevoid Basal Cell Carcinoma Syndrome (Gorlin-Goltz Syndrome)
  211. Vascular Cognitive Impairment through the Looking Glass of Transcranial Magnetic Stimulation
  212. The impact of drugs for multiple sclerosis on sleep
  213. Response to the letter to the editor “Cortical excitability in restless legs syndrome”
  214. Cholinergic circuitry functioning in patients with vascular cognitive impairment – no dementia
  215. Correlation between Motor Cortex Excitability Changes and Cognitive Impairment in Vascular Depression: Pathophysiological Insights from a Longitudinal TMS Study
  216. European Stroke Conference. 25th Conference, Venice, Italy, April 13-15, 2016: Abstract e-Book
  217. Effects of the modulation of sensory or motor cortical excitability by rTMS in restless legs syndrome
  218. Repetitive transcranial magnetic stimulation in patients with drug-resistant major depression: A six-month clinical follow-up study
  219. Acute Isolated Trochlear Nerve Palsy in a Patient with Cavernous Carotid Aneurysm and Visit-to-Visit Variability in Systolic Blood Pressure
  220. Effect of a Gluten-Free Diet on Cortical Excitability in Adults with Celiac Disease
  221. Poster Presentation with Discussion
  222. Motor cortex plasticity in subcortical ischemic vascular dementia: What can TMS say?
  223. Distinctive patterns of cortical excitability to transcranial magnetic stimulation in obstructive sleep apnea syndrome, restless legs syndrome, insomnia, and sleep deprivation
  224. Direct comparison of cortical excitability to transcranial magnetic stimulation in obstructive sleep apnea syndrome and restless legs syndrome
  225. Excitability of the Motor Cortex in De Novo Patients with Celiac Disease
  226. Epileptic Seizure as a Precipitating Factor of Vascular Progressive Supranuclear Palsy: A Case Report
  227. Different patterns of cortical excitability in major depression and vascular depression: a transcranial magnetic stimulation study
  228. P.2.h.003 Transcranial magnetic stimulation in major depression and vascular depression
  229. Transcranial Magnetic Stimulation in the Assessment of Motor Cortex Excitability and Treatment of Drug-Resistant Major Depression
  230. P.4.027 Six-month follow-up study of repetitive transcranial magnetic stimulation in the treatment of resistant major depressive disorder
  231. TMS follow-up study in patients with vascular cognitive impairment-no dementia
  232. Course of Atypical Manifestations of a Case of Charcot-Marie-Tooth Disease over 35 Years of Clinical Observation
  233. Preserved Transcallosal Inhibition to Transcranial Magnetic Stimulation in Nondemented Elderly Patients with Leukoaraiosis
  234. Focal neurological deficit in acute anemia: Case reports and review of the literature
  235. P.2.c.029 Repetitive transcranial magnetic stimulation and pharmacological treatment in patients with major depressive disorder
  236. Phenotypic heterogeneity in hereditary motor neuropathy type V: a new case report series
  237. Performance Evaluation of Classifiers in Distinguishing Mental Tasks from EEG Signals
  238. Motor cortex excitability in vascular depression
  239. Enhanced motor cortex facilitation in patients with vascular cognitive impairment-no dementia
  240. Transcranial magnetic stimulation in Alzheimer’s disease: a neurophysiological marker of cortical hyperexcitability
  241. A Review of Transcranial Magnetic Stimulation in Vascular Dementia
  242. An Interactive Tool for Customizing Clinical Transacranial Magnetic Stimulation (TMS) Experiments
  243. Clinical Presentation and Outcome of Geriatric Depression in Subcortical Ischemic Vascular Disease